Choose Tirzepatide if you want: The highest documented long-term weight loss Extensive global safety data A treatment available outside China Strong diabetes and cardiovascular benefits Choose Mazdutide if you want: Dramatic improvement in liver fat reduction Better metabolic benefits for Asian body profiles Added fat-burning from increased energy expenditure Access within China where it is approved Both medications represent a major leap forward in obesity and metabolic disease careand ongoing research will continue shaping how each is used across different populations
Robust clinical outcomes : Studies confirm that Wegovy can produce 15%20% average body weight loss, results that rival those achieved with Mounjaro
Current Neuropharmacology, 16(5), 566-583
Eating disorders are socially contagious and competitive
(Palo Alto Calif.) 2016;9:365385
Note you should not take Wegovy if: you are pregnant or trying to conceive you are breastfeeding your BMI is below 30, or below 27, and you do not have a weight-related medical condition you have ever had a serious allergic reaction to any of the ingredients in Wegovy, especially semaglutide Wegovy is also cautioned in some people, such as those with: diabetic retinopathy a history of pancreatitis severe, congestive heart failure You should speak to your doctor before using Wegovy pens if you have: kidney problems diabetes inflammation of your pancreas low blood sugar levels (hypoglycaemia) diabetic eye disease (retinopathy) A doctor may not be able to prescribe Wegovy in these cases
